How effective is Betaseron for Multiple Sclerosis Relapse? (a real world drug study)
Summary:
Overall ratings: 2.8/5 Long term ratings: 3.5/5
This is a phase IV clinical study of how effective Betaseron (interferon beta-1b) is for Multiple sclerosis relapse and for what kind of people. The study is created by eHealthMe from 4 Betaseron users and is updated continuously.
What is Betaseron?
Betaseron has active ingredients of interferon beta-1b. It is often used in multiple sclerosis. eHealthMe is studying from 26,886 Betaseron users. Check the latest studies of Betaseron.
What is Multiple sclerosis relapse?
Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,030 drugs and 943 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
4 people are studied for taking Betaseron in Multiple sclerosis relapse
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Betaseron effectiveness for Multiple sclerosis relapse (number of people):
Overall:
- not at all: 0
- somewhat: 2
- moderate: 1
- high: 1
- very high: 0
Long Term:
- not at all: 0
- somewhat: 0
- moderate: 1
- high: 1
- very high: 0
Gender of people who take Betaseron for Multiple sclerosis relapse *:
- female: 100 %
- male: 0.0 %
Age of people who take Betaseron for Multiple sclerosis relapse *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 25 %
- 40-49: 25 %
- 50-59: 50 %
- 60+: 0.0 %
Who find Betaseron more effective for Multiple Sclerosis Relapse?
Gender of people who take Betaseron for Multiple sclerosis relapse *:
- female: 100 %
- male: 0.0 %
Age of people who take Betaseron for Multiple sclerosis relapse *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
* Approximation only. Some reports may have incomplete information.
Do you take Betaseron?
- You can start a phase IV clinical trial to monitor Betaseron safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Betaseron (26,886 reports)
Treatments, associated drugs and conditions:
- Multiple sclerosis relapse (89,124 reports)
How the study uses the data?
The study is based on interferon beta-1b (the active ingredients of Betaseron) and Betaseron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Gabapentin and Emla - now
- Lamictal and Humira drug interactions for men aged 50-59 - a second ago
- Drug interactions of Ciprofloxacin and Nitrofurantoin - a second ago
- How effective is Ashwanga for Insomnia? - 2 seconds ago
- Could Enbrel cause Muscle Injury? - 3 seconds ago
- Drug interactions of Clindamycin Hydrochloride and Milk Thistle - 5 seconds ago
- High Blood Cholesterol and Infarction - 5 seconds ago
- Could Prednisolone cause Sepsis? - 6 seconds ago
- Could Restoril cause Oesophagitis? - 7 seconds ago
- Fainting and drugs of ingredients of dexamethasone; neomycin sulfate; polymyxin b sulfate - 10 seconds ago